Nucleot(s)ide Analogs for Chronic Hepatitis Virus Therapy: A Global Bibliometric Analysis (1986-2022)

Authors

  • Wahyu Aristyaning Putri Department of Tropical Biology, Faculty of Biology, Universitas Gadjah Mada, Indonesia
  • Jajar Setiawan Department of Physiology, Faculty of Medicine, Health Science and Nursing, Universitas Gadjah Mada, Indonesia
  • Fajar Sofyantoro Department of Tropical Biology, Faculty of Biology, Universitas Gadjah Mada, Indonesia
  • Dwi Sendi Priyono Department of Tropical Biology, Faculty of Biology, Universitas Gadjah Mada, Indonesia
  • Nur Indah Septriani Department of Tropical Biology, Faculty of Biology, Universitas Gadjah Mada, Indonesia
  • Wulan Usfi Mafiroh Department of Tropical Biology, Faculty of Biology, Universitas Gadjah Mada, Indonesia
  • Abdul Rahman Siregar Department of Tropical Biology, Faculty of Biology, Universitas Gadjah Mada, Indonesia
  • Yoshihiko Yano Department of Gastroenterology, Kobe University Hospital, Japan
  • Widya Wasityastuti Department of Physiology, Faculty of Medicine, Health Science and Nursing, Universitas Gadjah Mada, Indonesia

DOI:

https://doi.org/10.3329/bjms.v23i3.75098

Keywords:

Chronic Hepatitis Virus, Global Bibliometric

Abstract

Objectives: This  study  aimed  to  analyze  the  global  profile  of  the nucleotide/nucleoside  analogs  (NAs)  for  chronic  hepatitis virus therapy-related research.

Background: NAs, which closely resemble the structure of naturally occurring  nucleotides/nucleosides,  function  by  disrupting the elongation of the nascent DNA strand. These compounds are  considered  safe  and  well-tolerated,  as  they  specifically target  viral,  but  not  human,  polymerases  involved  in  DNA replication.  NAs  are  crucial  in  treating  viral  infections, including hepatitis, and are widely used due to their efficacy and safety. However, a study about trends in NAs for chronic hepatitis therapy-related research was never reported before.

Methods: The  NAs  for  chronic  hepatitis  therapy-related  research bibliometric  analysis  was  performed  on  articles  indexed  in the Scopus database from 1986 to 2022.

Results: The  total  number  of  articles  published  worldwide  is  2,341 documents,  with  an  annual  average  of  65  documents.  The United States generated the most articles (n = 486), followed by China (n = 454), France (n = 191), and Italy (n = 179). Since 1992, the number of publications has increased dramatically worldwide. Globally, liver cell carcinoma, antiviral therapy, hepatitis  B  (e)  antigen,  and  alanine  aminotransferase  are becoming hot research topics in the field.

Conclusions: This  study  provides  a  unique  composite  picture  of  NAs for  chronic  hepatitis  therapy-related  research  worldwide and  evaluates  research  productivity  from  1986  to  2022. This finding suggests that the prospects for interventions in chronic hepatitis remain promising.

Bangladesh Journal of Medical Science Vol. 23 No. 03 July’24 Page : 747-756

Downloads

Download data is not yet available.
Abstract
206
PDF
292

Downloads

Published

2024-07-29

How to Cite

Putri, W. A., Setiawan, J., Sofyantoro, F., Priyono, D. S., Septriani, N. I., Mafiroh, W. U., Siregar, A. R., Yano, Y., & Wasityastuti, W. (2024). Nucleot(s)ide Analogs for Chronic Hepatitis Virus Therapy: A Global Bibliometric Analysis (1986-2022). Bangladesh Journal of Medical Science, 23(3), 747–756. https://doi.org/10.3329/bjms.v23i3.75098

Issue

Vol. 23 No. 3 (2024)

Section

Original Articles

License

Copyright (c) 2024 Wahyu Aristyaning Putri

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:

  1. Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.

  2. Creative Commons Licence
    Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.